By
Adrianne Appel2023-09-14T18:55:00
Federal lawmakers shined a spotlight on artificial intelligence (AI) this week, raising the possibility that Congress will—eventually—legislate some controls on the burgeoning technology.
The rapid integration of AI into most sectors of the economy and life in general, including education and social media, has sparked high concern among many. The wide popularity of Open AI’s generative AI chatbot ChatGPT, launched 10 months ago, has escalated calls globally to place controls on that specific technology and others like it.
The European Union is set to finalize by the end of this year its AI regulation, which is based on the potential risks posed.
2024-05-06T20:23:00Z By Adrianne Appel
Microsoft published a public report covering its artificial intelligence endeavors and steps it is taking to make the controversial technology safe.
2023-11-07T20:12:00Z By Adrianne Appel
It’s all hands on deck at the White House to put into motion the dozens of directives in President Joe Biden’s executive order on artificial intelligence, according to Nik Marda, chief of staff for the Technology Division in the Office of Science and Technology Policy.
2023-10-20T14:14:00Z By Neil Hodge
Companies need to be aware of the legal risks and liabilities associated with their use of AI-based technologies, as technology firms are not the only ones in regulators’ sights, a panel of experts discussed at Compliance Week’s Europe conference in London.
2025-12-10T15:30:00Z By Neil Hodge
For the past decade, Europe has led in creating strong but flexible rules for data use and safe AI development. The EU’s new plans to simplify key data privacy and AI governance measures have received a mixed response.
2025-12-05T19:25:00Z By Oscar Gonzalez
The U.S. Securities and Exchange Commission’s (SEC) Division of Examinations released its 2026 examination priorities, which give companies a roadmap of areas of heightened risk and regulatory focus for next year.
2025-12-04T22:15:00Z By Ruth Prickett
Regulation is a matter of life and death in the pharmaceutical industry. Rules to combat practices that can kill have been in force for decades, but tech developments are rapidly creating new risks and focusing lawmakers’ attention on areas where some compliance teams may lack experience.
Site powered by Webvision Cloud